SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000930413-15-004855
Filing Date
2015-12-28
Accepted
2015-12-28 13:57:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 c83350_sc13g.htm SC 13G 117897
  Complete submission text file 0000930413-15-004855.txt   119526
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81034 | Film No.: 151308851
SIC: 2834 Pharmaceutical Preparations

Mailing Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830
Business Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830 203 971-3300
GREAT POINT PARTNERS LLC (Filed by) CIK: 0001281446 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G